Lewis Clayton Cantley Jr., Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 1,018 shares at $52.31 ($54K) on 2017-03-22, disclosed to the SEC on 2017-03-24.
Scheduled sale ($54k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.31 | 509 | $27K | 49.2% |
| 2 | $53.91 | 509 | $27K | 50.8% |
| Total | $53.11 avg | 1,018 | $54K | 100% |
| Filing → |
| AGIO | SELL | 2017-10-18 | $142K | — | Filing → |
| AGIO | SELL | 2017-09-15 | $131K | — | Filing → |
| AGIO | SELL | 2017-08-24 | $114K | — | Filing → |